Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide

Figure 1

Receiver operating characteristic curve analyses outcomes. (a) Progression-free survival. (b) Overall survival.

(a)

(b)